164 related articles for article (PubMed ID: 14680975)
21. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
[TBL] [Abstract][Full Text] [Related]
22. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
[TBL] [Abstract][Full Text] [Related]
23. [Genetic factors in familial combined hyperlipidemia and insulin resistance syndrome associated with dyslipidemia].
Moulin P
Ann Endocrinol (Paris); 1997; 58(4):287-91. PubMed ID: 9436476
[TBL] [Abstract][Full Text] [Related]
24. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
Arca M; Natoli S; Micheletta F; Riggi S; Di Angelantonio E; Montali A; Antonini TM; Antonini R; Diczfalusy U; Iuliano L
Free Radic Biol Med; 2007 Mar; 42(5):698-705. PubMed ID: 17291993
[TBL] [Abstract][Full Text] [Related]
25. The level and species of plasma non-esterified fatty acids are not related to elevated plasma apolipoprotein B levels in familial combined hyperlipidemia.
Shamir R; Williams KJ; Cortner JL; Hudgins LC; Levine LC; McGee-Harper M; Fisher EA
J Med; 2001; 32(5-6):349-63. PubMed ID: 11958280
[TBL] [Abstract][Full Text] [Related]
26. Relationship between familial combined hyperlipidemia and insulin resistance.
Jackuliaková D; Vaverková H; Karásek D
Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
[TBL] [Abstract][Full Text] [Related]
27. Quantitative trait loci for apolipoprotein B, cholesterol, and triglycerides in familial combined hyperlipidemia pedigrees.
Cantor RM; de Bruin T; Kono N; Napier S; van Nas A; Allayee H; Lusis AJ
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1935-41. PubMed ID: 15308552
[TBL] [Abstract][Full Text] [Related]
28. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
Chen Y; Li Y; Wang Y; Wen Y; Sun C
Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
[TBL] [Abstract][Full Text] [Related]
29. In vivo modulation of plasma free fatty acids in patients with familial combined hyperlipidemia using lipid-lowering medication.
Meijssen S; Derksen RJ; Bilecen S; Erkelens DW; Cabezas MC
J Clin Endocrinol Metab; 2002 Apr; 87(4):1576-80. PubMed ID: 11932285
[TBL] [Abstract][Full Text] [Related]
30. Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?
Karjalainen L; Pihlajamäki J; Karhapää P; Laakso M
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1548-53. PubMed ID: 9763525
[TBL] [Abstract][Full Text] [Related]
31. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
[TBL] [Abstract][Full Text] [Related]
32. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia.
Meijssen S; Cabezas MC; Twickler TB; Jansen H; Erkelens DW
J Lipid Res; 2000 Jul; 41(7):1096-102. PubMed ID: 10884291
[TBL] [Abstract][Full Text] [Related]
33. Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)gamma-2 with longevity.
Barbieri M; Bonafè M; Rizzo MR; Ragno E; Olivieri F; Marchegiani F; Franceschi C; Paolisso G
Exp Gerontol; 2004 Jul; 39(7):1095-100. PubMed ID: 15236769
[TBL] [Abstract][Full Text] [Related]
34. [Disorder of lipid metabolism in visceral fat syndrome--relation to familial combined hyperlipidemia].
Ishigami M; Nakamura T; Matsuzawa Y
Nihon Rinsho; 2002 May; 60(5):868-74. PubMed ID: 12029987
[TBL] [Abstract][Full Text] [Related]
35. Altered vascular responses to circulating angiotensin II in familial combined hyperlipidemia.
Jörneskog G; Kahan T; Ekholm M; Bröijersén A; Wallén NH
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1037-44. PubMed ID: 18799967
[TBL] [Abstract][Full Text] [Related]
36. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
37. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia.
Aitman TJ; Godsland IF; Farren B; Crook D; Wong HJ; Scott J
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):748-54. PubMed ID: 9108790
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha is a marker of familial combined hyperlipidemia, independently of metabolic syndrome.
Pauciullo P; Gentile M; Marotta G; Baiano A; Ubaldi S; Jossa F; Iannuzzo G; Faccenda F; Panico S; Rubba P
Metabolism; 2008 Apr; 57(4):563-8. PubMed ID: 18328361
[TBL] [Abstract][Full Text] [Related]
39. Confirmed locus on chromosome 11p and candidate loci on 6q and 8p for the triglyceride and cholesterol traits of combined hyperlipidemia.
Naoumova RP; Bonney SA; Eichenbaum-Voline S; Patel HN; Jones B; Jones EL; Amey J; Colilla S; Neuwirth CK; Allotey R; Seed M; Betteridge DJ; Galton DJ; Cox NJ; Bell GI; Scott J; Shoulders CC
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2070-7. PubMed ID: 14500288
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
Moon MK; Cho YM; Jung HS; Park YJ; Yoon KH; Sung YA; Park BL; Lee HK; Park KS; Shin HD
Diabet Med; 2005 Sep; 22(9):1161-6. PubMed ID: 16108843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
